The Thrombolysis In Myocardial Infarction risk index predicted in-hospital mortality in non-ST-segment elevation myocardial infarction
- Clinical Profile and Mortality of ST-Segment Elevation Myocardial Infarction Patients Receiving Thrombolytic Therapy in the Middle East. Panduranga, Prashanth; Al-Zakwani, Ibrahim; Sulaiman, Kadhim; Al-Habib, Khalid; Al Suwaidi, Jassim; Al-Motarreb, Ahmed; Alsheikh-Ali, Alawi; Al Saif, Shukri; Al Faleh, Hussam; Almahmeed, Wael; Asaad, Nidal; Amin, Haitham; Al-Lawati, Jawad; Hersi, Ahmad // Heart Views;Apr-Jun2012, Vol. 13 Issue 2, p35
Objective: Little is known about thrombolytic therapy patterns in patients with ST-elevation myocardial infarction (STEMI) in the Middle East. The objective of this study was to evaluate the clinical profile and mortality of STEMI patients who arrived in hospital within 12 hours from pain onset...
- Even in the thrombolytic era, more than one-third of MIs are fatal within 24 hours. // Modern Medicine;Mar95, Vol. 63 Issue 3, p47
Presents an abstract of the article `Mortality Within 24 Hours of Thrombolysis For Myocardial Infarction: The Importance of Early Reperfusion,' by N.S. Kleiman, H.D. White, et al dated December 1994.
- Left ventricular thrombus formation after acute myocardial infarction. Delewi, Ronak; Zijlstra, Felix; Piek, Jan J. // Heart;Dec2012, Vol. 98 Issue 23, p1742
The article offers information on the risks related to the formation of left ventricular (LV) thrombus after the occurrence of acute myocardial infarction (AFI). It informs that the risk of LV thrombus formation is highest during the first 3 months of following acute myocardial infarction. It...
- National health care costs of peripheral arterial disease in the Medicare population. Hirsch, Alan T.; Hartman, Lacey; Town, Robert J.; Virnig, Beth A. // Vascular Medicine;2008, Vol. 13 Issue 3, p209
Lower extremity peripheral arterial disease (PAD) is prevalent in the Medicare population and is associated with high rates of myocardial infarction, stroke, amputation, and death. Nevertheless, national health expenditures for PAD are not known. We hypothesized that PAD-related costs are high,...
- Oscillatory functions affecting outcome of coronary heart disease: The hazard of too much or too... Wolf, Stewart // Integrative Physiological & Behavioral Science;Apr-Jun95, Vol. 30 Issue 2, p118
Identifies the physiological and behavioral indicators predictive of sudden arrhythmic death in patients who had experienced myocardial infarction in the past. Non-determinants of cardiac mortality; Degree of instability required in the proper physiological balance.
- Mortality risk higher for MI patients who receive blood transfusions. // Cardiology Today;Feb2013, Vol. 16 Issue 2, p21
The article discusses a study published in the "Archives of Internal Medicine," which found a higher mortality risk among patients with myocardial infarction (MI) who receive blood transfusions.
- Always look on the bright sideâ€¦. McCrory, P. // British Journal of Sports Medicine;Feb2007, Vol. 41 Issue 2, p63
The author reflects on the increasing number cardiovascular mortality in sports. According to the author, several studies have demonstrated increased cardiovascular mortality with the outcome of local and national football teams. He pointed that mostly is male mortality from myocardial...
- Serum Chelatable Redox-Active Iron Is an Independent
Predictor of Mortality After Myocardial Infarction in
Individuals With Diabetes. Sulieman, Mahmoud; Asleh, Rabea; Cabantchik, Zvi I.; Breuer, William; Aronson, Doron; Suleiman, Abeer; Miller-Lotan, Rachel; Hammerman, Haim; Levy, Andrew P. // Diabetes Care;Nov2004, Vol. 27 Issue 11, p2730
Presents a study which examined the association of labile plasma iron (LPI) with myocardial infarction and mortality in individuals with diabetes. Blood collection and measurement of LIP; Research design and methodology; Results and discussion; Conclusions.
- DES show mortality benefit in AMI. Lindsay, Alistair C.; Qureshi, Katie // Heart;Jan2009, Vol. 95 Issue 1, p93
The article reports on the study about drug-eluting stents (DES), which shows mortality benefit in acute myocardial infarction (AMI). The study was based on an unselected, population based cohort of 7217 patients undergoing PCI with stenting for AMI over an 18-month period in Massachusetts...